The association between sleep characteristics and prothrombotic markers in a population-based sample: Chicago Area Sleep Study

Background and aimShort sleep duration and poor quality sleep are associated with coronary heart disease (CHD) mortality; however, the underlying pathophysiologic process remains unclear. Sleep apnea may confound the association because of its relationship with formation of thrombi, the vascular occlusive process in CHD. We tested whether sleep duration and quality were associated with prothrombotic biomarkers in adults with a low probability of apnea.MethodsWe included adults aged 35–64 years recruited from the community and who had an apnea hypopnea index <15 after one night of screening (n = 506). Sleep duration and maintenance were determined from 7 days of wrist actigraphy; daytime sleepiness was estimated using the Epworth Sleepiness Scale. Factor VIII (FVIII), von Willebrand factor (vWF), thrombin antithrombin (TAT) complexes, and plasminogen activator inhibitor-1 (PAI-1) were measured in fasting blood.ResultsSleep duration, maintenance, and daytime sleepiness were not associated with FVIII, vWf, or TAT. Sleep maintenance was modestly inversely associated with higher levels of log-transformed PAI-1 (β = −0.07, standard error (SE) = 0.03 per 4.8%, p = 0.04) following adjustment for demographic characteristics, cardiovascular risk factors, and body mass index (BMI).ConclusionsMild impairment in sleep was modestly associated with activation of coagulation; further study is needed to evaluate the role of fibrinolytic factors in sleep-mediated coronary thrombosis.